Biowearable startup takes aim at diabetes epidemic

November 19, 2020 //By Rich Pell
Biowearable startup takes aim at diabetes epidemic
Biowearable system startup Levels has announced that it has raised $12 million in seed funding to bring biowearables into the mainstream and improve metabolic health by promoting behavior change based on personal data.

The company's biowearable technology provides real-time glucose data to enable users to optimize diet, improve performance, and accelerate recovery. In the same way fitness trackers are commonly worn to quantify physical activity and exercise, says the company, it measures the impact of one's diet and lifestyle on metabolic health by pairing continuous glucose monitoring (CGM) technology with intelligent software.

"You shouldn't need a PhD in nutrition or human physiology to know what to eat for lunch," says Josh Clemente, Levels Founder and President. "Levels is the first product that takes the guesswork out of daily lifestyle choices with personalized, objective data. By leveraging continuous glucose monitoring, Levels helps users close the loop between overall health and daily choices around food, exercise, sleep, and stress management to support long-term metabolic health."

Its technology, says the company, is designed to help reverse the trend of metabolic dysfunction among Americans, over 120 million of whom have prediabetes or diabetes, according to reports. And, says the company, 84% of people with prediabetes don't even know they have it.

"Optimizing metabolic function can improve energy, endurance, memory, mood, and cognitive performance," says Dr. Casey Means, Co-founder of Levels. "Seven of the 10 leading causes of death in the US are strongly related to metabolic dysfunction. Levels helps you improve metabolic fitness by alerting you to foods that negatively impact glucose levels. Armed with this information, you can take control of your metabolic health and make healthier lifestyle decisions."

The company's month-long Levels program includes two 14-day CGM sensors and access to the Levels app, which provides real-time analysis on how food, exercise, and other lifestyle decisions are impacting the user's health. Currently in a closed beta, the company says it has a 50,000+ person waitlist and will be available for consumer purchase in early 2021.

The seed funding round was led by a16z, one of Silicon Valley's top venture capital firms whose portfolio includes Airbnb,

Vous êtes certain ?

Si vous désactivez les cookies, vous ne pouvez plus naviguer sur le site.

Vous allez être rediriger vers Google.